52 1023122 0 1
52 1023122 0 1
REPORT
Investigation Observed Value Unit Biological Reference
Interval
HAEMATOLOGY
Blood Group & Rh Type (EDTA Blood 'B' 'Positive'
/Slide Agglutination)
INTERPRETATION: Note: Slide method is screening method. Kindly confirm with Tube method for transfusion.
Complete Blood Count With - ESR
Haemoglobin (EDTA Blood/ 16.1 g/dL 13.5 - 18.0
Automated Blood cell Counter)
Packed Cell Volume 48.0 % 42 - 52
(PCV)/Haematocrit (EDTA Blood/
Automated Blood cell Counter)
RBC Count (EDTA Blood/Automated 5.55 mill/cu.mm 4.7 - 6.0
Blood cell Counter)
Mean Corpuscular Volume(MCV) 87.0 fL 78 - 100
(EDTA Blood/Automated Blood cell
Counter)
Mean Corpuscular Haemoglobin 29.0 pg 27 - 32
(MCH) (EDTA Blood/Automated
Blood cell Counter)
Mean Corpuscular Haemoglobin 33.5 g/dL 32 - 36
concentration(MCHC) (EDTA Blood/
Automated Blood cell Counter)
RDW-CV 13.1 % 11.5 - 16.0
RDW-SD 39.89 fL 39 - 46
REPORT
Investigation Observed Value Unit Biological Reference
Interval
Total Leukocyte Count (TC) (EDTA 6900 cells/cu.mm 4000 - 11000
Blood/Automated Blood cell Counter)
Neutrophils (Blood) 55.9 % 40 - 75
REPORT
Investigation Observed Value Unit Biological Reference
Interval
MPV* (Blood/Calculated) 07.81 fL 7.9 - 13.7
REPORT
Investigation Observed Value Unit Biological Reference
Interval
BIOCHEMISTRY
Glucose (Fasting) - FBS (Plasma - F/ 91 mg/dL Normal : <=100
Pre Diabetic : 101 - 125
GOD- POD) Diabetic : >=126
ADA Recommendation 2013.
INTERPRETATION: NOTE : Factors such as type and time of food intake, infection, physical or psychological stress, exercise
and drugs can influence the blood glucose level.
Creatinine (Serum/Jaffe Kinetic) 1.2 mg/dL 0.9 - 1.3
INTERPRETATION: Elevated Creatinine values are encountered in increased muscle mass, severe dehydration, Pre-eclampsia,
increased ingestion of cooked meat, consuming Protein/ Creatine supplements, Diabetic Ketoacidosis, prolonged fasting, renal
dysfunction and drugs such as cefoxitin ,cefazolin, ACE inhibitors ,angiotensin II receptor antagonists,N-acetylcyteine ,
chemotherapeutic agent such as flucytosine etc.
Cholesterol Total (Serum/Cholesterol 206 mg/dL Optimal: < 200
Borderline: 200 - 239
oxidase/Peroxidase) High Risk: >= 240
REPORT
Investigation Observed Value Unit Biological Reference
Interval
SEROLOGY
VDRL/RPR (Serum/Slide Non Reactive Non Reactive
Flocculation)
HIV (ELISA METHOD)*
HIV (IV generation) (Serum) Non Reactive S/CO Non Reactive<1.0 Reactive>=1.0
REPORT
Investigation Observed Value Unit Biological Reference
Interval
CLINICAL PATHOLOGY
URINE COMPLETE ANALYSIS
PHYSICAL EXAMINATION
Colour (Urine) Pale yellow
Volume (Urine) 15 mL
Appearance (Urine) Clear Clear
CHEMICAL EXAMINATION
pH (Urine) 6.0 4.6 - 8.0
REPORT
Investigation Observed Value Unit Biological Reference
Interval
RBCs (Urine) Nil /hpf 0-1
-- End of Report --